Objectives: To evaluate correlation of exhaled breath condensate (EBC) nitrite and nitrate concentrations with disease severity in cystic fi brosis (CF) patients. Background: Nitrites and nitrates are products of oxidative metabolism of nitric oxide. Impaired metabolism of nitric oxide plays a role in pathogenesis of CF. Methods: EBC was collected from 46 stable CF patients and from 21 healthy controls. EBC concentrations of nitrites and nitrates were correlated with parameters of lung disease and nutritional status and with systemic infl ammatory markers. Results: EBC nitrates concentrations in CF patients were lower than in healthy subjects (5.8 vs 14.3 μmol/l, p<0.001). They correlated positively with FEV 1 (p=0.025) and serum albumin values (p=0.016) and negatively with chest radiograph Northern score (p=0.015) and serum C-reactive protein values (p=0.005). EBC nitrites concentrations in CF patients did not differ from those in healthy subjects and were not correlated to any studied parameter. Conclusions: EBC nitrates concentrations correlate with disease severity in CF patients and are lower than in healthy subjects (Tab. 4, Fig. 1 
Abbreviations: BMI -body mass index, CF -cystic fi brosis, CRP -C-reactive protein, EBC -exhaled breath condensate, eNO -exhaled nitric oxide, FEV 1 -forced expiratory volume in fi rst second, IgG -immunoglobulin G, iNOS -inducible nitric oxide synthase.
Bronchopulmonary disease in cystic fi brosis (CF) is characterised by impaired mucociliary clearance, chronic bacterial infection and neutrophilic infl ammation (1) . Beside the dysfunction of cystic fi brosis transmembrane conductance regulator (CFTR), an impaired nitric oxide (NO) metabolism plays a role in the pathogenesis of CF (2). The values of exhaled NO (eNO) in CF adults are lower when compared with healthy subjects and are positively correlated with pulmonary function (3, 4, 5).
Nitrites (NO 2 ) and nitrates (NO 3 ) are products of oxidative metabolism of NO. The studies measuring NO 2 and NO 3 in sputum or bronchoalveolar lavage fl uid have found either unchanged or increased concentrations of these metabolites in patients with CF compared to healthy subjects (6, 7, 8, 9 ). The concentrations of NO 2 and NO 3 in sputum correlated positively with pulmonary function (6).
Exhaled breath condensate (EBC) is collected by cooling of expired gas during tidal breathing. This is a non-invasive and easyto-perform method of sampling the secretions from airways (10). The concentrations of NO 2 in EBC in CF patients were similar or higher when compared with healthy controls and did not correlate with pulmonary function (11, 12) . On the other hand, the concentrations of NO 3 in EBC were similar or lower in CF patients than in controls (13, 14, 15) .
In the present study, the relationships between concentrations of NO metabolites and clinical characteristics of CF patients were analysed by using a commercial device for EBC collection and a thoroughly validated analytical method for measurement of EBC concentrations of NO 2 and NO 3 in a large study population.
Methods
Patients with CF were consecutively recruited into the study at the Pulmonary Department of Charles University, 2nd Faculty of Medicine, and University Hospital Motol in Prague, Czech Repub-lic. The diagnosis of CF was confi rmed in all patients by repeated sweat test with chloride concentration exceeding 60 mmol/l and by mutation analysis of CFTR gene. Respiratory disorders other than CF and smoking history were the main exclusion criteria.
The examinations were performed during routine out-patient visits in a stable phase of the disease. Demographic parameters (sex and age) and sputum microbiology (predominant bacteria) were collected from patients' records. Written informed consent was obtained from all subjects. The study was approved by Ethical Committee of Charles University, 2nd Faculty of Medicine, Prague, Czech Republic. Control healthy subjects were staff members or students with no history of smoking or any chronic lung disease.
EBC collection was performed according to ERS/ATS guidelines using ECoScreen device (Jaeger, Germany) (10). Obtained EBC was frozen immediately and stored at -80 °C until examined. EBC NO 2 and NO 3 concentrations were assayed by liquid chromatography after derivatization with diaminonaphthalene, as described previously (16) . EBC collection was carried out in antemeridian hours and was preceded by chest physiotherapy early in the morning with nebulized dornase alpha. Lung function tests were completed after the collection of EBC.
Lung function tests were performed using Jaeger MasterLab device (Jaeger, Germany) according to ERS/ATS guidelines with reversibility testing (with 400 μg of salbutamol) (17) . Better results from pre-/postbronchodilatory values of forced expiratory volume in the fi rst second (FEV 1 ) were reported. Chest radiographs were done and scored using the Northern score (18) . Body weight and body height were measured under standard conditions and body mass indexes (BMI) were calculated. Blood for routine biochemical analyses was sampled by venepuncture under standard conditions. Routine biochemical analyses, i.e. serum C-reactive protein (CRP), immunoglobulin G (IgG) and albumin were performed using standard techniques.
Data were expressed as arithmetic or geometric means (for normally or log-normally distributed data, respectively) and 95 % confi dence intervals (CI) for means. Comparisons between groups were made using Fisher's exact test and two-sample t-test. The values were log-transformed when the distribution of original variables was highly skewed (CRP, NO 2 and NO 3 ). Evaluation of correlations between variables was made using Spearman's rank correlation coeffi cient (r S ). A p-value <0.05 was considered statistically signifi cant. Statistical software Stata, release 9 (Stata-Corp LP, College Station, TX) was used for analysis.
Results
Forty-six patients with CF and 21 healthy subjects were enrolled in the study. No differences were found in the demographic data between these two groups. Gram-negative bacteria, i.e. Pseudomonas aeruginosa and Burkholderia cepacia complex, predominated in sputum cultures in 40 patients (Tab. 1).
Clinical characteristics of CF patients and results of laboratory tests are presented for the whole group as well as separately for females and males. No sex-related differences were found except for lower serum albumin values in females (Tab. 2).
Concentrations of NO 3 were lower in CF patients than in healthy subjects, while the levels of NO 2 did not differ between these groups. Sex did not infl uence the EBC NO metabolites concentrations in CF patients (Tab. 3).
No signifi cant correlation was found between EBC NO 2 concentration and any of clinical parameters in CF patients. The NO 3 values were correlated with several clinical characteristics. The NO 3 concentration correlated positively with FEV 1 value and serum albumin concentration. Negative correlation was observed between NO 3 concentration and Northern score and also with serum CRP concentration (Tab. 4). Signifi cant correlations are depicted in Figure 1 . 
Discussion
CF is generally considered to be a disease with decreased eNO. The recent publications report eNO in CF to be similar (19, 20) or lower (21, 22, 23) than in controls. Positive correlation with FEV 1 value (3, 5, 24) or disease severity (Shwachman-Kulczycki score) (8) is also reported.
The issues regarding eNO levels in CF seem to be different in children with early lung disease than in adults with advanced bronchopulmonary involvement. The eNO value in children is initially normal and decreases subsequently (19) . Moreover, children with CF have a higher alveolar NO concentration together with normal bronchial NO fl ux (20) . This is confi rmable with a higher macrophages count in alveoli in CF foetuses before infection (25) and with increased expression of inducible NO synthase (iNOS) in infl ammatory cells (26) . The expression of iNOS in airway epithelial cells is normal (9) or decreased (23) .
On the other hand, alveolar NO concentration is normal and bronchial NO fl ux is decreased in CF adults with advanced lung disease (4). The expression of iNOS in both alveolar macrophages and airway epithelial cells decreases as the infl ammation progresses and is inversely related to the neutrophils count in bronchoalveolar lavage fl uid (9).
Beside iNOS, the levels of eNO are infl uenced by arginase activity. Arginase reduces the availability of arginine for NO synthase. Arginase activity in CF is higher and negatively correlated to FEV 1 . Antibiotic therapy reduces arginase activity in CF (3). Studies with oral L-arginine supplementation in CF patients were conducted. However, they showed diverse results with regard to eNO levels (27, 28) .
A further factor taking part in lowered eNO in CF is the retention of NO in respiratory secretions. It was found that similarly to FEV 1 , eNO undergoes changes after dornase alpha treatment (29) . In such condition, NO is subject of oxidative metabolism, which is increased in CF airways (30) . We should also take into consideration the bacterial metabolism of NO in CF airways. In chronic P. aeruginosa infection, NO is reduced to ammonia (31) .
Tab. 4. Spearman's correlations (r S ) between clinical characteristics of CF patients and EBC concentrations of nitrites and nitrates.
The infl uence of alimentary NO 2 and NO 3 on eNO in CF is subject of conjecture. In healthy persons, diets rich in NO 3 lead to an increase in eNO (32) . Since 80 % of alimentary NO 3 originates in vegetables (33), we cannot exclude the infl uence of food on low eNO in CF. The reason is that high-calorie, high-fat diet in CF patients may contain a low amount of vegetables. However, CF patients have higher serum concentrations of NO 2 and NO 3 than controls (26) .
The issues regarding NO 2 and NO 3 concentrations in EBC are also complex. They include the production of NO 2 and NO 3 by oxidative metabolism of NO in airways together with secretion of alimentary NO 3 in saliva and their reduction to NO 2 by oropharyngeal bacteria (34) . Swallowed NO 2 may be further reduced in acid juice in stomach to NO. NO 3 -rich diet leads to higher eNO in healthy people, in whom both alveolar NO concentration and bronchial NO fl ux increase. Chlorhexidine mouthwash leads to a decrease in alveolar NO concentration at baseline and after dietary NO 3 load (35) . In CF patients and in healthy controls, chlorhexidine mouthwash leads to a decrease in eNO and EBC concentration of NO 2 . EBC concentration of NO 2 positively correlates with salivary NO 2 concentration. Furthermore, a decrease in NO 2 concentration in saliva after chlorhexidine mouthwash is coupled with an increase in NO 3 concentration. However, EBC concentration of NO 3 is not affected by oropharyngeal disinfection (15) . In accordance with these fi ndings, EBC concentration of NO 2 in CF patients is not correlated to pulmonary function (FEV 1 ), chest radiograph (Crispin-Norman score) and clinical status (modifi ed Shwachman-Kulczycki score) and also do not predict pulmonary exacerbation (36) . In our study, we obtained similar results.
There is a lack of data dealing with the relation of EBC NO 3 concentration and clinical and laboratory parameters in CF. In our study, we found a signifi cant correlation of EBC concentration of NO 3 with pulmonary function, chest radiograph score and serum concentrations of albumin and CRP. On the basis of these results, the measurement of EBC concentration of NO 3 in CF patients seems to give more valuable information than the examination of EBC NO 2 concentration. However, the bacterial metabolism of NO 3 to NO 2 in lower airways (similarly to oropharyngeal tract) could contribute to a decrease in NO 3 concentration in EBC. It was shown that the presence of membrane-bound nitrate reductase is critical for P. aeruginosa growth in CF respiratory secretions (37) and that sputum concentration of NO 3 increases after antibiotic treatment of pulmonary exacerbation in CF (7).
Correlations of EBC concentration of NO 3 and serum albumin and CRP may be considered surprising. Serum albumin is one of nutritional markers as well as an important antioxidant. The relation of nutritional status and NO synthase activity was studied in rats. In malnourished rats, NO synthase activity was decreased (38) . Similarly, malnourished CFTR -/-mice had a decreased amount of NO 2 in lung tissue (39) . Positive correlation of EBC concentration of NO 3 with serum albumin concentration could refl ect higher NO production in persons with better nutritional status. However, we found no correlation of EBC NO 3 concentration with BMI. Serum CRP concentration in our CF population may be considered too high for a stable phase of disease. Nevertheless, our values correspond to data in CF adults in other studies (40, 41) . Moreover, an airway colonisation with P. aeruginosa and/or B. cepacia complex was present in our study group in 87 % of subjects and measurements in such groups of CF adults by others give similar data (42, 43) . The information about relations of EBC concentration of both NO 2 and NO 3 with systemic infl ammatory markers is sparse. For example, Ho and co-workers found a positive correlation of EBC NO 2 concentration and circulating plasma leukocytes and neutrophils (44) . In our study, the negative correlation of EBC NO 3 concentration and serum CRP concentration probably refl ects the systemic infl ammatory response to the severity of bronchopulmonary involvement or above mentioned airway colonisation with typical gramnegative bacteria (45, 46) . EBC concentrations of NO 2 and NO 3 in healthy subjects observed in our study were in excellent agreement with the results of other investigators obtained using the same collection device and analytical method (47, 48) .
In summary, EBC NO 3 concentrations correlate with disease severity in CF patients and are lower than in healthy subjects.
